Anti-Inflammatory, Antioxidant, and Anti-Atherosclerotic Effects of Natural Supplements on Patients With Fmf-Related Aa Amyloidosis: a Non-Randomized 24-Week Open-Label Interventional Study

dc.authorid GARCIA-BOURNISSEN, FACUNDO/0000-0002-8732-247X
dc.authorid Poddighe, Dimitri/0000-0001-6431-9334
dc.authorid Ucuncuoglu, Didar/0000-0002-2640-5976
dc.authorid Demirkaya, Erkan/0000-0003-4525-1789
dc.authorid sezer, siren/0000-0002-7326-8388
dc.authorid Stenvinkel, Peter/0000-0002-8785-4820
dc.authorid honca, tevfik/0000-0003-3723-1374
dc.authorscopusid 57190093613
dc.authorscopusid 13003928900
dc.authorscopusid 57217041113
dc.authorscopusid 6507293750
dc.authorscopusid 57762018200
dc.authorscopusid 6506823277
dc.authorscopusid 15758674100
dc.authorwosid GARCIA-BOURNISSEN, FACUNDO/E-8286-2015
dc.authorwosid Poddighe, Dimitri/AAI-5712-2020
dc.authorwosid Ucuncuoglu, Didar/B-1929-2016
dc.authorwosid Demirkaya, Erkan/F-5082-2019
dc.authorwosid sezer, siren/JYQ-2550-2024
dc.contributor.author Romano, Micol
dc.contributor.author Garcia-Bournissen, Facundo
dc.contributor.author Piskin, David
dc.contributor.author Rodoplu, Ulkumen
dc.contributor.author Piskin, Lizzy
dc.contributor.author Elzagallaai, Abdelbaset A.
dc.contributor.author Demirkaya, Erkan
dc.date.accessioned 2024-07-05T15:17:42Z
dc.date.available 2024-07-05T15:17:42Z
dc.date.issued 2022
dc.department Atılım University en_US
dc.department-temp [Romano, Micol; Demirkaya, Erkan] Univ Western Ontario, Schulich Sch Med & Dent, Div Paediat Rheumatol, Dept Paediat, London, ON N6A 5W9, Canada; [Romano, Micol; Piskin, David; Demirkaya, Erkan] Univ Western Ontario, Schulich Sch Med Dent, Canadian Behcet & Autoinflammatory Dis Ctr CAN BE, London, ON N6A 5W9, Canada; [Garcia-Bournissen, Facundo] Univ Western Ontario, Schulich Sch Med & Dent, Div Paediat Clin Pharmacol, Dept Paediat, London, ON N6A 5W9, Canada; [Garcia-Bournissen, Facundo; Piskin, David; Demirkaya, Erkan] Univ Western Ontario, Schulich Sch Med & Dent, Dept Epidemiol & Biostat, London, ON N6A 3K7, Canada; [Rodoplu, Ulkumen] Emergency Med Assoc Turkey All, TR-35220 Izmir, Turkey; [Piskin, Lizzy] Univ Western Ontario, Robarts Res Inst, London, ON N6A 3K7, Canada; [Elzagallaai, Abdelbaset A.] Univ Western Ontario, Schulich Sch Med & Dent Physiol & Pharmacol, London, ON N6A 3K7, Canada; [Tuncer, Tunc] Epigenet Hlth Solut, Biochem Unit, TR-06810 Ankara, Turkey; [Sezer, Siren] Atilim Univ, Div Nephrol, Fac Med, TR-06830 Ankara, Turkey; [Ucuncuoglu, Didar] Cankiri Karatekin Univ, Dept Food Engn, Fac Engn, TR-18100 Cankiri, Turkey; [Honca, Tevfik] Gur Life Hosp, Biochem Unit, TR-26320 Eskisehir, Turkey; [Poddighe, Dimitri] Nazarbayev Univ, Dept Med, Sch Med, Nur Sultan 010000, Kazakhstan; [Poddighe, Dimitri] Univ Med Ctr, Natl Res Ctr Maternal & Child Hlth, Clin Acad, Dept Pediat, Nur Sultan 010000, Kazakhstan; [Yavuz, Izzet] Lokman Hekim Univ, Dept Nephrol, TR-06510 Ankara, Turkey; [Stenvinkel, Peter] Karolinska Univ Hosp, Karolinska Inst, Dept Renal Med 99, S-17164 Stockholm, Sweden; [Yilmaz, Mahmut Ilker] Ctr Epigenet Hlth Solut, Nephrol Unit, TR-06810 Ankara, Turkey en_US
dc.description GARCIA-BOURNISSEN, FACUNDO/0000-0002-8732-247X; Poddighe, Dimitri/0000-0001-6431-9334; Ucuncuoglu, Didar/0000-0002-2640-5976; Demirkaya, Erkan/0000-0003-4525-1789; sezer, siren/0000-0002-7326-8388; Stenvinkel, Peter/0000-0002-8785-4820; honca, tevfik/0000-0003-3723-1374 en_US
dc.description.abstract We aimed to evaluate the effect of a combination of natural products on parameters related to inflammation, endothelial dysfunction, and oxidative stress in a cohort of familial Mediterranean fever (FMF) patients with Serum Amyloid A amyloidosis, in a non-randomized, 24-week open-label interventional study. Morinda citrifolia (anti-atherosclerotic-AAL), omega-3 (anti-inflammatory-AIC), and extract with Alaskan blueberry (antioxidant-AOL) were given to patients with FMF-related biopsy-proven AA amyloidosis. Patients were >18 years and had proteinuria (>3500 mg/day) but a normal estimated glomerular filtration rate (eGFR). Arterial flow-mediated dilatation (FMD), carotid intima media thickness (CIMT), and serum biomarkers asymmetric dimethylarginine (ADMA), high sensitivity C-reactive protein (hs-CRP), pentraxin (PTX3), malondialdehyde (MDA), Cu/Zn-superoxide dismutase (Cu/Zn-SOD), and glutathione peroxidase (GSH-Px) were studied at baseline and after 24 weeks of treatment. A total of 67 FMF-related amyloidosis patients (52 male (77.6%); median age 36 years (range 21-66)) were enrolled. At the end of a 24-week treatment period with AAL, AIC, and AOL combination therapy, ADMA, MDA, PTX3, hsCRP, cholesterol, and proteinuria were significantly decreased compared to baseline, while CuZn-SOD, GSH-Px, and FMD levels were significantly increased. Changes in inflammatory markers PTX3, and hsCRP were negatively correlated with FMD change, and positively correlated with decreases in proteinuria, ADMA, MDA, cholesterol, and CIMT. Treatment with AAL, AIC and AOL combination for 24 weeks were significantly associated with reduction in inflammatory markers, improved endothelial functions, and oxidative state. Efficient control of these three mechanisms can have long term cardiovascular and renal benefits for patients with AA amyloidosis. en_US
dc.description.sponsorship Department of Pediatrics, University of Western Ontario, Canada en_US
dc.description.sponsorship The authors thank all the patients who took part in this study. M.R. is the recipient of matching the fund (Department of Pediatrics, University of Western Ontario, Canada) bursary for international clinical fellowship in Behcet and Autoinflammatory Disease Center. en_US
dc.identifier.citationcount 2
dc.identifier.doi 10.3390/life12060896
dc.identifier.issn 2075-1729
dc.identifier.issue 6 en_US
dc.identifier.pmid 35743929
dc.identifier.scopus 2-s2.0-85132728702
dc.identifier.uri https://doi.org/10.3390/life12060896
dc.identifier.uri https://hdl.handle.net/20.500.14411/1775
dc.identifier.volume 12 en_US
dc.identifier.wos WOS:000816662000001
dc.language.iso en en_US
dc.publisher Mdpi en_US
dc.relation.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
dc.rights info:eu-repo/semantics/openAccess en_US
dc.scopus.citedbyCount 4
dc.subject familial Mediterranean fever en_US
dc.subject AA amyloidosis en_US
dc.subject natural supplementation en_US
dc.subject endothelial dysfunction en_US
dc.subject oxidative stress en_US
dc.subject inflammation en_US
dc.title Anti-Inflammatory, Antioxidant, and Anti-Atherosclerotic Effects of Natural Supplements on Patients With Fmf-Related Aa Amyloidosis: a Non-Randomized 24-Week Open-Label Interventional Study en_US
dc.type Article en_US
dc.wos.citedbyCount 3
dspace.entity.type Publication

Files

Collections